Difference between revisions of "Part:BBa K2973000"
Akatsaouni (Talk | contribs) |
|||
| (16 intermediate revisions by 3 users not shown) | |||
| Line 3: | Line 3: | ||
<partinfo>BBa_K2973000 short</partinfo> | <partinfo>BBa_K2973000 short</partinfo> | ||
| − | This composite part consists of T7 Promoter(BBa_J64997) and T7 Terminator(BBa_K731721), Ribosomal Binding Site(BBa_B0034), CDS of β-lactamase without the signal peptide. β-lactamase (EC 3.5.2.6) is a small monomeric enzyme(29kDa) that is produced by bacteria and gives them resistance to antibiotics with β-lactam ring because of its ability to hydrolyze the amide bond in the β-lactam ring. This ability can be exploited in order to use β-lactamase as a protein reporter by providing the enzyme with its chromogenic substrate Nitrocefin. Nitrocefin is a chromogenic cephalosporin first reported in 1972 as a novel and straightforward substrate used to detect bacteria resistant to β-lactam antibiotics. Normally, a nitrocefin solution has a yellow color, but after its hydrolysis by β-lactamase, the color of the solution turns red, allowing that way the detection of the enzyme. | + | This composite part consists of T7 Promoter(<partinfo>BBa_J64997</partinfo>)and T7 Terminator(<partinfo>BBa_K731721</partinfo>), Ribosomal Binding Site(<partinfo>BBa_B0034</partinfo>), CDS of β-lactamase without the signal peptide. β-lactamase (EC 3.5.2.6) is a small monomeric enzyme(29kDa) that is produced by bacteria and gives them resistance to antibiotics with the β-lactam ring because of its ability to hydrolyze the amide bond in the β-lactam ring. This ability can be exploited in order to use β-lactamase as a protein reporter by providing the enzyme with its chromogenic substrate Nitrocefin. Nitrocefin is a chromogenic cephalosporin first reported in 1972 as a novel and straightforward substrate used to detect bacteria resistant to β-lactam antibiotics. Normally, a nitrocefin solution has a yellow color, but after its hydrolysis by β-lactamase, the color of the solution turns red, allowing that way the detection of the enzyme. |
===Usage and Biology=== | ===Usage and Biology=== | ||
| − | =Documentation= | + | ==Documentation== |
| − | This part was used as a positive control for our <i>in vitro</i> protein synthesis experiments. | + | This part was used as a <b>positive control</b> for our <i>in vitro</i> protein synthesis experiments. |
| − | In order to test the sensitivity of our regulatory system we performed experiments by adding different concentrations of trigger and reducing the time of the <i>in vitro</i> protein synthesis reaction. | + | In order to test the sensitivity of our regulatory system we performed experiments by adding different concentrations of the trigger and reducing the time of the <i>in vitro</i> protein synthesis reaction. |
| − | The <i>in vitro</i> transcription/ translation reactions were done using the PURExpress® In Vitro Protein Synthesis kit. A reaction without a trigger sequence was included, as a negative control and a leakage measure. Furthermore, in order to reduce the cost of the reaction, we lowered the reaction volume from 25 to 7 μL. | + | The <i>in vitro</i> transcription/ translation reactions were done using the PURExpress® <i>In Vitro</i> Protein Synthesis kit. A reaction without a trigger sequence was included, as a negative control and a leakage measure. Furthermore, in order to reduce the cost of the reaction, we lowered the reaction volume from 25 to 7 μL. |
| − | Firstly, we tested the functionality of our regulatory system by adding following concentrations of trigger: | + | Firstly, we tested the functionality of our regulatory system by adding the following concentrations of trigger: |
• <b>0.3nM</b> (Fig 2.) | • <b>0.3nM</b> (Fig 2.) | ||
| Line 23: | Line 23: | ||
• <b>75nM</b> (Fig 1.) | • <b>75nM</b> (Fig 1.) | ||
| − | |||
<html> | <html> | ||
| Line 36: | Line 35: | ||
</html> | </html> | ||
| − | <b>Figure 1.</b> Enzymatic assay of | + | <b>Figure 1.</b> Enzymatic assay of β-lactamase with nitrocefin as its substrate, when expressed from a non-regulated and a toehold-regulated construct in a cell-free system. Error bars correspond to the standard deviation of n=2 replicates. Blank was subtracted. After the 3-hour incubation in the cell-free system, the chromogenic substrate of β-lactamase, nitrocefin, was added and an additional 45-minute enzymatic assay was performed in the plate reader, at 37 ℃. |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
<!-- --> | <!-- --> | ||
Latest revision as of 12:28, 21 October 2019
T7-RBS-β-Lactamase-No Signal peptide
This composite part consists of T7 Promoter(BBa_J64997)and T7 Terminator(BBa_K731721), Ribosomal Binding Site(BBa_B0034), CDS of β-lactamase without the signal peptide. β-lactamase (EC 3.5.2.6) is a small monomeric enzyme(29kDa) that is produced by bacteria and gives them resistance to antibiotics with the β-lactam ring because of its ability to hydrolyze the amide bond in the β-lactam ring. This ability can be exploited in order to use β-lactamase as a protein reporter by providing the enzyme with its chromogenic substrate Nitrocefin. Nitrocefin is a chromogenic cephalosporin first reported in 1972 as a novel and straightforward substrate used to detect bacteria resistant to β-lactam antibiotics. Normally, a nitrocefin solution has a yellow color, but after its hydrolysis by β-lactamase, the color of the solution turns red, allowing that way the detection of the enzyme.
Usage and Biology
Documentation
This part was used as a positive control for our in vitro protein synthesis experiments.
In order to test the sensitivity of our regulatory system we performed experiments by adding different concentrations of the trigger and reducing the time of the in vitro protein synthesis reaction. The in vitro transcription/ translation reactions were done using the PURExpress® In Vitro Protein Synthesis kit. A reaction without a trigger sequence was included, as a negative control and a leakage measure. Furthermore, in order to reduce the cost of the reaction, we lowered the reaction volume from 25 to 7 μL.
Firstly, we tested the functionality of our regulatory system by adding the following concentrations of trigger:
• 0.3nM (Fig 2.)
• 3nM (Fig 2.)
• 7nM (Fig 1., Fig 2.)
• 75nM (Fig 1.)
Figure 1. Enzymatic assay of β-lactamase with nitrocefin as its substrate, when expressed from a non-regulated and a toehold-regulated construct in a cell-free system. Error bars correspond to the standard deviation of n=2 replicates. Blank was subtracted. After the 3-hour incubation in the cell-free system, the chromogenic substrate of β-lactamase, nitrocefin, was added and an additional 45-minute enzymatic assay was performed in the plate reader, at 37 ℃.
Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12INCOMPATIBLE WITH RFC[12]Illegal NheI site found at 851
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]